Anticomplement therapy in bullous pemphigoid

被引：1
作者：
Hashimoto, T. [1 ]
Kanazawa, N. [2 ]
Inoue, N. [3 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Dept Dermatol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan
[2] Wakayama Med Univ, Dept Dermatol, Wakayama, Japan
[3] Wakayama Med Univ, Dept Mol Genet, Wakayama, Japan
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2019年 / 181卷 / 03期
关键词：
COMPLEMENT;
D O I：
10.1111/bjd.18229
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：448 / 449
页数：2
相关论文
共 10 条
  • [1] BLACK MM, 1989, ACTA DERM-VENEREOL, P96
  • [2] Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients
    Chiorean, Roxana M.
    Baican, Adrian
    Mustafa, Mayson B.
    Lischka, Annette
    Leucuta, Daniel-Corneliu
    Feldrihan, Vasile
    Hertl, Michael
    Sitaru, Cassian
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [3] Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab
    Fairley, Janet A.
    Baum, Christian L.
    Brandt, Debra S.
    Messingham, Kelly A. N.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (03) : 704 - 705
  • [4] C3 glomerulopathy: a new classification
    Fakhouri, Fadi
    Fremeaux-Bacchi, Veronique
    Noel, Laure-Helene
    Cook, H. Terence
    Pickering, Matthew C.
    [J]. NATURE REVIEWS NEPHROLOGY, 2010, 6 (08) : 494 - 499
  • [5] Bullous pemphigoid autoantibody-mediated complement fixation is abolished by the low-molecular-weight heparin tinzaparin sodium
    Gutjahr, A.
    Heck, F.
    Emtenani, S.
    Hammers, A. -K.
    Hundt, J. E.
    Muck, P.
    Siegel, D. L.
    Schmidt, E.
    Stanley, J. R.
    Zillikens, D.
    Hammers, C. M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (03) : 593 - 594
  • [6] Granular C3 Dermatosis
    Hashimoto, Takashi
    Tsuruta, Daisuke
    Yasukochi, Atsushi
    Imanishi, Hisayoshi
    Sekine, Hideharu
    Fujita, Teizo
    Wanibuchi, Hideki
    Gi, Min
    Karpati, Sarolta
    Sitaru, Cassian
    Zone, John J.
    Endo, Daisuke
    Abe, Shinichi
    Nishino, Tomoya
    Koji, Takehiko
    Ishii, Norito
    [J]. ACTA DERMATO-VENEREOLOGICA, 2016, 96 (06) : 748 - 753
  • [7] THE ROLE OF COMPLEMENT IN EXPERIMENTAL BULLOUS PEMPHIGOID
    LIU, Z
    GIUDICE, GJ
    SWARTZ, SJ
    FAIRLEY, JA
    TILL, GO
    TROY, JL
    DIAZ, LA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) : 1539 - 1544
  • [8] Update on the pathogenesis of bullous pemphigoid: An autoantibody-mediated blistering disease targeting collagen XVII
    Nishie, Wataru
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2014, 73 (03) : 179 - 186
  • [9] Low-molecular-weight heparin inhibition in classical complement activaton pathway during pregnancy
    Oberkersch, Roxana
    Attorresi, Alejandra I.
    Calabrese, Graciela C.
    [J]. THROMBOSIS RESEARCH, 2010, 125 (05) : E240 - E245
  • [10] IGG SUBCLASSES OF INTERCELLULAR AND BASEMENT-MEMBRANE ZONE ANTIBODIES - THE RELATIONSHIP TO THE CAPABILITY OF COMPLEMENT-FIXATION
    YAMADA, H
    HASHIMOTO, T
    NISHIKAWA, T
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 92 (04) : 585 - 587
1